ADX-10061
ADX-10061 Uses, Dosage, Side Effects, Food Interaction and all others data.
ADX10061 is a potent, selective antagonist of the dopamine D1 receptor. It is developed by Addex Pharmaceuticals for the treatment of nicotine dependence.
Trade Name | ADX-10061 |
Generic | ADX-10061 |
Type | |
Formula | C19H20N2O4 |
Weight | Average: 340.379 Monoisotopic: 340.142307132 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in sleep disorders, smoking cessation, and substance abuse.
How ADX-10061 works
Activation of dopamine D1 receptor in the brain is implicated in reward-seeking behaviours and cue-induced craving, and is the fundamental mechanism by which nicotine causes addiction. Both reward (the “feel good” sensation a smoker gets from a cigarette) and cue (the habitual situations that trigger the craving to smoke) are important drivers of the desire to smoke. Blocking the D1 receptor will, it is hoped, reduce the association with the stimuli specific to reward-seeking behaviour that lead smokers who are trying to quit starting smoking again.
Innovators Monograph
You find simplified version here ADX-10061